SBFM Q3 2019 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$7,326-94.7% YoY

Gross Profit

$2,03327.8% margin

Operating Income

-$202,640-2766.0% margin

Net Income

-$350,241-4780.8% margin

EPS (Diluted)

$-9216.87

QoQ Revenue Growth

+141.5%

Cash Flow

Operating Cash Flow

-$86,536

Free Cash Flow

-$86,051

Stock-Based Comp.

$74,100

Balance Sheet

Total Assets

$146,335

Total Liabilities

$889,191

Stockholders' Equity

-$742,856

Cash & Equivalents

$81,973

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7,326	$136,939	-94.7%
Gross Profit	$2,033	$34,137	-94.0%
Operating Income	-$202,640	-$288,825	+29.8%
Net Income	-$350,241	-$907,556	+61.4%